Virus Diseases Research
At Institutul National De Boli Infectioase Prof.Dr.Matei Bals in Bucharest, the clinical trial portfolio focuses on virus diseases, with studies centered on COVID-19, chronic hepatitis B, chronic hepatitis D, and HIV-1. The research is designed to assess new treatments, understand antiviral effects, and support better management of infectious diseases.
- Studies in COVID-19 are evaluating whether new outpatient treatments can reduce hospitalization and death.
- Chronic hepatitis B research includes testing antiviral options in children, adolescents, and adults to improve safety and infection control.
- Chronic hepatitis D infection studies are examining treatment safety and the longer-term impact on liver disease progression.
- HIV-1 research is exploring new approaches aimed at expanding future antiviral treatment choices.
Overall, the site supports clinical research that combines antiviral therapy evaluation with efforts to improve disease outcomes across a range of serious viral infections.
